BUZZ-NeoGenomics rises on better-than-expected 2025 revenue forecast

Reuters
15 Jan
BUZZ-<a href="https://laohu8.com/S/NEO">NeoGenomics</a> rises on better-than-expected 2025 revenue forecast

** Shares of cancer testing services co NeoGenomics NEO.O rise ~5% to $14.47 premarket

** NEO forecast FY 2025 revenue in the range of $735 mln to $745 mln vs analysts' average estimate of $727.70 mln - data compiled by LSEG

** 10 of 15 brokerages rate stock "buy" or higher and 5 "hold"; their median PT is $19.50 - data compiled by LSEG

** NEO gained 3.3% in 2024

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10